Williams v. Boehringer Ingelheim Pharmaceuticals, Inc.
Certiorari Denied
Petition for certiorari denied on February 20, 2024.
Issue
Whether an interlocutory ruling that dismisses some (but not all) of a plaintiff"s claims with prejudice become an appealable "final decision" if the plaintiff voluntarily dismisses her action under Federal Rule of Civil Procedure 41(a).
Jul 25, 2023Application (23A79) to extend the time to file a petition for a writ of certiorari from August 16, 2023 to October 15, 2023, submitted to Justice Thomas.
Jul 27, 2023Application (23A79) granted by Justice Thomas extending the time to file until September 15, 2023.
Sep 15, 2023Petition for a writ of certiorari filed. (Response due October 20, 2023)Oct 16, 2023Waiver of right of respondents Boehringer Ingelheim Pharmaceuticals, Inc. and Boehringer Ingelheim USA Corp. to respond filed.Nov 1, 2023DISTRIBUTED for Conference of 11/17/2023.
Nov 6, 2023Response Requested. (Due December 6, 2023)
Nov 13, 2023Motion to extend the time to file a response from December 6, 2023 to December 22, 2023, submitted to The Clerk.Nov 14, 2023Motion to extend the time to file a response is granted and the time is extended to and including December 22, 2023.
Dec 21, 2023Brief of respondents Boehringer Ingelheim Pharmaceuticals, Inc. et al. in opposition filed.Jan 4, 2024Reply of petitioner Marilyn Williams filed.Jan 10, 2024DISTRIBUTED for Conference of 2/16/2024.
Feb 20, 2024Petition DENIED.
Recommended Citation: Williams v. Boehringer Ingelheim Pharmaceuticals, Inc., SCOTUSblog, https://www.scotusblog.com/cases/williams-v-boehringer-ingelheim-pharmaceuticals-inc/